Metraipolis › archive › dc_4a8544aa910d
Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospital — Europe PMC PMID:42108490
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42108490
- DOI
- 10.1186/s13756-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T09:10:14.563Z
- SHA-256 of the archived text
38346cba3b300cbb13456d4cccc00ded5f6ac5e3f7a787df9c80a976f2ec49fb- Stable URL of this page
https://metraipolis.com/documento/dc_4a8544aa910d
How to cite
Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospital — Europe PMC PMID:42108490 — Europe PMC (en), https://europepmc.org/article/MED/42108490 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a8544aa910d (Metraipolis archive dc_4a8544aa910d, sha256 38346cba3b300cbb13456d4cccc00ded5f6ac5e3f7a787df9c80a976f2ec49fb)
BibTeX
@misc{dc4a8544aa910d,
title = {Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospital — Europe PMC PMID:42108490},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42108490},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a8544aa910d; sha256 38346cba3b300cbb13456d4cccc00ded5f6ac5e3f7a787df9c80a976f2ec49fb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42108490. Agents can read the archived copy with the MCP tool read_document.